Skip to Main Content

Cefuroxime Pediatric Dose Calculator

Calculate cefuroxime (Ceftin) doses for children by weight for otitis media, sinusitis, pharyngitis, UTI, and Lyme disease.

Updated

Cefuroxime Pediatric Dose Calculator

Evidence-based weight-adjusted dosing

Based on AAP Clinical Practice Guideline·Updated Mar 2026·Free, no signup

How to Use This Calculator

Enter Weight

Input the child's weight in kilograms.

Select Indication

Choose the infection type to determine dosing intensity.

Choose Formulation

Select the suspension concentration or tablet strength.

Review Dosing

Check per-dose and daily amounts with clinical guidance.

How We Calculate

Cefuroxime axetil is a second-generation cephalosporin with broad-spectrum activity. For otitis media and sinusitis, the standard pediatric dose is 30 mg/kg/day divided BID (max 500 mg/dose) per AAP guidelines. For pharyngitis and UTI, 20 mg/kg/day divided BID (max 250 mg/dose) is recommended. Cefuroxime is also an IDSA-recommended first-line oral option for early Lyme disease at 30 mg/kg/day.

The oral suspension has lower bioavailability than tablets and should always be given with food to enhance absorption. Tablets and suspension are NOT interchangeable on a mg-for-mg basis due to different absorption profiles. The suspension is available in 125 mg/5 mL and 250 mg/5 mL concentrations.

Cefuroxime is generally well tolerated with a low cross-reactivity risk (~1-2%) in penicillin-allergic patients. It does not require refrigeration after reconstitution, which is a practical advantage. This tool is for educational reference only.

Sources & References

  • AAP Clinical Practice Guideline — Diagnosis and Management of Acute Otitis Media (aap.org)
  • IDSA Clinical Practice Guidelines for Lyme Disease (idsociety.org)
  • Lexicomp Pediatric Drug Information — Cefuroxime (wolterskluwer.com)

Data last verified:

Frequently Asked Questions

Yes, cefuroxime should always be taken with food to maximize absorption. The oral suspension bioavailability increases from about 37% to 52% when taken with food. The tablets also have improved absorption with food. This is an important counseling point that significantly affects drug efficacy — skipping food can result in subtherapeutic drug levels at the infection site.

Cefuroxime tablets have a strong bitter taste and are film-coated to mask this. Crushing the tablets exposes the bitter drug and makes it very difficult for children to take. The oral suspension is strongly preferred for children who cannot swallow tablets whole. If crushing is absolutely necessary, mixing with a strongly flavored food like chocolate pudding may help, but the suspension remains the better option.

For early Lyme disease (erythema migrans), cefuroxime axetil is given at 30 mg/kg/day divided BID with a maximum of 500 mg per dose. The typical treatment course is 14-21 days per IDSA guidelines. Cefuroxime is one of three recommended oral options for early Lyme, alongside doxycycline (for children 8 and older) and amoxicillin. It is particularly useful for young children who cannot take doxycycline.

Second-generation cephalosporins like cefuroxime have a cross-reactivity rate of approximately 1-2% with penicillin allergy. For children with mild penicillin reactions (rash), cefuroxime is generally considered safe. However, children with a history of anaphylaxis or severe allergic reaction to penicillin should avoid cephalosporins unless cleared by an allergist through formal testing.

Cefuroxime is a second-generation cephalosporin with broader gram-negative coverage than first-generation agents like cephalexin, while maintaining good gram-positive activity. Compared to third-generation agents like cefdinir, cefuroxime has slightly less gram-negative coverage but better stability against certain beta-lactamases. Its twice-daily dosing and Lyme disease indication make it a versatile choice in pediatrics.

Reconstituted cefuroxime suspension can be stored at room temperature (2-30°C) or refrigerated. It does not require refrigeration, which is a practical advantage over many other antibiotic suspensions. The reconstituted suspension is stable for 10 days. Shake well before each dose and use an oral syringe or measuring cup for accurate dosing.

The standard treatment duration for acute otitis media with cefuroxime is 10 days. For children 6 years and older with mild symptoms, some guidelines allow a shorter 5-7 day course, though this should be at the prescriber's discretion. For recurrent otitis media or treatment failure with first-line agents, the full 10-day course is recommended.

ToolSite Team

We build free, accurate calculators.